ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,180.74
      1.03%
      US Tech 100
      17,599.60
      1.04%
      Dow Jones
      38,852.27
      0.46%
      Brent Oil
      83.345
      -0.16%
      Bitcoin
      63,920.34
      1.19%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Virios Therapeutics Inc (VIRI)

      7. Virios Therapeutics Inc (VIRI) News

      VIRI

      Virios Therapeutics (VIRI)

      Virios Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VIRI
      DateTimeSourceHeadlineSymbolCompany
      05/02/20249:15AMGlobeNewswire Inc.Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:VIRIVirios Therapeutics Inc
      03/26/20249:15AMGlobeNewswire Inc.Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVIDNASDAQ:VIRIVirios Therapeutics Inc
      03/08/20245:00PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:VIRIVirios Therapeutics Inc
      03/06/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
      03/01/20249:10AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VIRIVirios Therapeutics Inc
      02/29/20249:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
      02/29/20249:15AMGlobeNewswire Inc.Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:VIRIVirios Therapeutics Inc
      02/28/20241:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/20241:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/202412:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/202412:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/202412:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/202412:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/202412:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/202412:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VIRIVirios Therapeutics Inc
      02/28/20249:15AMGlobeNewswire Inc.Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming MilestonesNASDAQ:VIRIVirios Therapeutics Inc
      02/27/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
      02/02/20244:31PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VIRIVirios Therapeutics Inc
      01/22/20249:33AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VIRIVirios Therapeutics Inc
      01/22/20249:00AMGlobeNewswire Inc.Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVIDNASDAQ:VIRIVirios Therapeutics Inc
      01/03/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
      01/02/20247:05AMGlobeNewswire Inc.Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVIDNASDAQ:VIRIVirios Therapeutics Inc
      11/13/20239:10AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VIRIVirios Therapeutics Inc
      11/13/20237:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
      11/13/20237:05AMGlobeNewswire Inc.Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:VIRIVirios Therapeutics Inc
      11/07/20237:29AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
      11/06/20237:05AMGlobeNewswire Inc.Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023NASDAQ:VIRIVirios Therapeutics Inc
      11/02/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
      10/12/20237:05AMGlobeNewswire Inc.Virios Therapeutics to Present at the ThinkEquity Conference on Thursday, October 19, 2023NASDAQ:VIRIVirios Therapeutics Inc
      09/18/20237:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VIRIVirios Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:VIRI